Safety and Efficacy of Pegteograstim on Chemotherapy-induced Neutropenia in Children and Adolescents With Solid Tumors
Conclusions:
Pegteograstim is safe and shows comparable efficacy to conventional filgrastim in children and adolescents. Randomized controlled trials are needed to confirm its safety and efficacy.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Original Articles Source Type: research
More News: Cancer & Oncology | Chemotherapy | Children | Cough | Filgrastim | Hematology | Hives | Neulasta | Neupogen | Pain | Pediatrics | Polyethylene Glycol | Skin | Study | Toxicology